Comparison

Tirzepatide vs Semaglutide: Which Is Better for Weight Loss?

The two most effective weight loss medications go head-to-head. Here's an honest comparison to help you understand the differences.

Updated January 2026 | 12 min read

Quick Comparison

Before we dive into details, here's the summary:

Feature Tirzepatide Semaglutide
Brand names Mounjaro, Zepbound Ozempic, Wegovy
Mechanism GLP-1 + GIP (dual) GLP-1 only
Avg weight loss ~21% ~15%
Injection Weekly Weekly
Max dose 15mg 2.4mg
Manufacturer Eli Lilly Novo Nordisk

The headline: tirzepatide typically produces more weight loss on average. But both are highly effective, and the "best" choice depends on your individual situation.

How They Work Differently

Semaglutide mimics one hormone: GLP-1. This hormone reduces appetite, slows gastric emptying, and improves blood sugar control. For a full explanation, see what is semaglutide.

Tirzepatide mimics two hormones: GLP-1 and GIP. This dual action appears to produce stronger effects on appetite, metabolism, and potentially fat burning. Learn more in our tirzepatide guide.

Think of semaglutide as pressing one button that reduces appetite. Tirzepatide presses two buttons simultaneously, producing a potentially stronger and more comprehensive effect.

The GIP component in tirzepatide may also:

  • Enhance the satiety signals beyond GLP-1 alone
  • Improve how your body handles dietary fat
  • Help balance the GLP-1 effects on the stomach (potentially reducing nausea)

Weight Loss Results

A published head-to-head clinical trial directly compared tirzepatide and semaglutide. This is the gold standard comparison because it used the same population and conditions.

Head-to-Head Trial Results (72 weeks):

  • Tirzepatide (15mg): Average weight loss of 20.2%
  • Semaglutide (2.4mg): Average weight loss of 13.7%
  • Difference: Tirzepatide produced about 47% more weight loss

For someone starting at 100kg:

  • Tirzepatide: ~20kg weight loss
  • Semaglutide: ~14kg weight loss

Both are substantial, but the difference is meaningful for many people.

What about individual variation?

These are averages. Some people respond better to semaglutide, while others respond better to tirzepatide. There's no way to predict which will work better for you without trying.

For timeline expectations, see our GLP-1 weight loss timeline.

Side Effects Comparison

Both medications share similar side effects since they work on the same pathways. The most common issues are gastrointestinal:

Side Effect Tirzepatide Semaglutide
Nausea ~25-30% ~30-35%
Diarrhea ~15-20% ~15-20%
Constipation ~10-15% ~15-20%
Vomiting ~10-15% ~10-15%

Some studies suggest tirzepatide may cause slightly less nausea than semaglutide, possibly because the GIP component helps balance GLP-1's stomach effects. However, individual experiences vary widely.

For tips on managing these effects, see managing nausea with GLP-1 medications.

Dosing Differences

Both medications use gradual dose escalation, but the schedules differ:

Tirzepatide: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg

Semaglutide: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg

Tirzepatide has more dose steps, which allows for finer adjustment. Some people find their optimal dose before reaching maximum.

Both require patience. Rushing through dose escalation typically increases side effects without improving results.

For detailed schedules, see tirzepatide dosing and semaglutide dosing.

Cost Considerations

In Nigeria, brand-name versions of both medications are expensive and often difficult to find. Most people access compounded versions.

Compounded tirzepatide and semaglutide are generally similar in price when obtained through legitimate sources. The choice usually comes down to effectiveness rather than cost.

For guidance on accessing these medications, see how to get GLP-1 medications in Nigeria.

Which Should You Choose?

Consider tirzepatide if:

  • You want maximum weight loss potential
  • You have type 2 diabetes (it works well for blood sugar too)
  • You've tried semaglutide without adequate results
  • Side effects on semaglutide were problematic

Consider semaglutide if:

  • It's more readily available in your area
  • You prefer a medication with longer track record
  • Cost is a significant factor and semaglutide is cheaper
  • You're starting GLP-1 therapy for the first time

The honest answer: Both work very well. If tirzepatide is available, its stronger average effect makes it a reasonable first choice. But semaglutide is also highly effective, and some people actually respond better to it.

Common Questions

Can I switch from semaglutide to tirzepatide?

Yes. Work with your doctor to transition. You typically don't need to start tirzepatide at the lowest dose if you're already on a therapeutic dose of semaglutide.

Is tirzepatide always better?

On average, yes. But individual responses vary. Some people do better on semaglutide. The only way to know is to try.

Can I take both together?

No. These medications work on similar pathways and should not be combined. Use one or the other.

Which has been around longer?

Semaglutide (2017 approval) has a longer track record than tirzepatide (2022 approval). Both have been studied extensively.

Key Takeaways

  • Tirzepatide produces ~21% average weight loss vs ~15% for semaglutide
  • Tirzepatide targets two hormones (GLP-1 + GIP), semaglutide targets one
  • Side effects are similar for both medications
  • Both are highly effective - individual response varies

Ready to Start Your Weight Loss Journey?

Our medical team can help you choose the right medication for your goals.

Get Started Today

Related Articles

References

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021.
  2. Davies M, et al. Semaglutide 2.4 mg Once Weekly in Adults with Overweight or Obesity and Type 2 Diabetes (STEP 2). Lancet. 2021.

Medically Reviewed by Dr. Babatunde Afolabi

MBBS, FRCP, PhD - Endocrinology

Content reviewed by qualified healthcare professionals for accuracy.